A Music Therapy Study for Blood Cancer Survivors With Cognitive Difficulties
Purpose
Research has shown that music-based activities may help improve brain functions, such as attention, memory, and executive function. Because of this past research, the researchers are doing this study to find out whether telehealth music therapy is a practical treatment for cognitive difficulties in blood cancer survivors. The researchers will also study whether music therapy and music education help improve cognitive function and other common symptoms such as anxiety, depression, and/or tiredness.
Conditions
- Blood Cancer
- Lymphoma
- Leukemia
- Myeloma
Eligibility
- Eligible Ages
- Over 18 Years
- Eligible Sex
- All
- Accepts Healthy Volunteers
- Yes
Inclusion Criteria
- English-proficient, aged 18 or older - Diagnosis of lymphoma, leukemia, or myeloma - Stable oncologic disease or no evidence of disease as indicated in the medical chart or by the oncology team - Score of <54 on the FACT-Cog PCI subscale - Minimum life expectancy of one year as per clinician assessment - Patient should be able to understand and complete all study assessments on their own. - Eligible patient should be able to understand informed consent and provide signed informed consent in English.
Exclusion Criteria
- Less than 3 months since completion of surgery, radiation, induction chemotherapy (for newly diagnosed or relapsed disease), transplantation, or immunotherapy (e.g., CAR T-Cell, bispecific antibodies) - If there is a defined treatment period, the patient must be at least 3 months from treatment completion - If the patient is on continuous therapy, patient must have completed at least 6 months of the therapy - Maintenance therapies are allowed - Received music therapy (MT) in the past year - Current music training, >6 months of music training in the past 10 years, or plan to initiate music training during the study - No access to an internet-connected device - Active suicidal ideation, bipolar, schizophrenia, or substance abuse - BOMC score ≥10 (indicative of dementia) - Uncorrectable visual, auditory, or motor impairments - Initiation or altered dose of sedative, stimulant, or anti-cholinergic medications in the past month or plan to initiate these medications during the study, as these are known to impact cognitive function - Initiation of any other interventions for CRCD (e.g., cognitive rehabilitation) in the past month or plan to initiate these interventions during the study, as these are known to impact cognitive function
Study Design
- Phase
- N/A
- Study Type
- Interventional
- Allocation
- Non-Randomized
- Intervention Model
- Parallel Assignment
- Primary Purpose
- Treatment
- Masking
- None (Open Label)
Arm Groups
| Arm | Description | Assigned Intervention |
|---|---|---|
|
Experimental Music Therapy/MT |
Participants will receive 12, weekly 60-minute MT sessions (+/- 1 week) with homework in-between sessions to reinforce in-session concepts, practice musical skills, and serve as transitions to subsequent sessions |
|
|
Active Comparator Therapist Attention-Music Education/TAME control |
Patients will receive 12, weekly 60-minute Therapist Attention-Music Education/TAME sessions (+/- 1 week) with homework in-between sessions to reinforce in-session concepts and serve as transitions to subsequent sessions. The TAME control group will involve board-certified music therapists guiding participants through music listening exercises. |
|
|
No Intervention Wait-List Control/WLC |
The Wait-List Control/WLC group will receive usual care from healthcare providers and complete the same assessments as the other groups. The WLC will have the option of receiving either 12 sessions of MT or 12 sessions of TAME intervention when the study concludes after the 24-week waiting period. The WLC participants will choose which intervention (MT or TAME) they wish to receive. |
|
Recruiting Locations
Memorial Sloan Kettering Basking Ridge (All protocol activities)
Basking Ridge, New Jersey 07920
Basking Ridge, New Jersey 07920
Contact:
Kevin Liou, MD
646-608-8559
Kevin Liou, MD
646-608-8559
Memorial Sloan Kettering Monmouth (All protocol activities)
Middletown, New Jersey 07748
Middletown, New Jersey 07748
Contact:
Kevin Liou, MD
646-608-8559
Kevin Liou, MD
646-608-8559
Memorial Sloan Kettering Bergen (All protocol activities)
Montvale, New Jersey 07645
Montvale, New Jersey 07645
Contact:
Kevin Liou, MD
646-608-8559
Kevin Liou, MD
646-608-8559
Memorial Sloan Kettering Cancer Center Suffolk - Commack (All protocol activities)
Commack, New York 11725
Commack, New York 11725
Contact:
Kevin Liou, MD
646-608-8559
Kevin Liou, MD
646-608-8559
Memorial Sloan Kettering Westchester (All protocol activities)
Harrison, New York 10604
Harrison, New York 10604
Contact:
Kevin Liou, MD
646-608-8559
Kevin Liou, MD
646-608-8559
Memorial Sloan Kettering Cancer Center (All protocol activities)
New York, New York 10065
New York, New York 10065
Contact:
Kevin Liou, MD
646-608-8563
Kevin Liou, MD
646-608-8563
Memorial Sloan Kettering Nassau (All protocol activities)
Uniondale, New York 11553
Uniondale, New York 11553
Contact:
Kevin Liou, MD
646-608-8559
Kevin Liou, MD
646-608-8559
More Details
- Status
- Recruiting
- Sponsor
- Memorial Sloan Kettering Cancer Center